Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.

Objectives: Cisplatin chemotherapy is associated with an increased risk of ototoxic changes. The incidence of hearing loss after the 1st cisplatin-infusion session is only scarcely mentioned in the international literature. With increasing survival rates, prevention and/or early detection of ototoxicity are important for providing management options.